FH and primary membranoproliferative glomerulonephritis: FH-autoantibodies were also described in MPGN patients, usually with a low titer, with predominantly N-terminal binding sites and various functional effects if determined, ranging from clearly pathogenic role to mild impairment of FH functions [21,22,23,24,25,26].